stockrowTransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −31.0%
- Free cash flow
- −55.4%
- Total debt
- −89.3%
Quarter to September 2026, against a year earlier
Follow TMDX
Alert me
TransMedics Group, Inc. (TMDX) EV/FCF
As of 5 November 2026, TransMedics Group, Inc. (TMDX) trades at a EV/FCF of 62.5×. Over the past ten years it has ranged from −79.5× (June 2025) to 268× (June 2025); the current reading is higher than 96% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 31.1× | — |
| FY2024 | −27.8× | — |
| FY2023 | −13.6× | — |
| FY2022 | −26.8× | — |
| FY2021 | −14.6× | — |
| FY2020 | −13.0× | — |
| FY2019 | −6.9× | — |
| FY2018 | −2.0× | — |
| FY2017 | −2.0× | — |
| FY2016 | −2.0× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 73.8× | 117.18% |
| Jun 2026 | 34.0× | 34.87% |
| Mar 2026 | 25.2× | (19.08%) |
| Dec 2025 | 31.1× | (3.01%) |
| 31 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| BFLY Butterfly Network, Inc. compare | −56.1× |
| NVCR NovoCure Limited compare | −52.9× |
| ESTA Establishment Labs Holdings Inc. compare | −51.7× |
| ALMR Alamar Biosciences, Inc. compare | −14.9× |
| INSP Inspire Medical Systems, Inc. compare | 16.4× |
| UFPT UFP Technologies, Inc. compare | 38.7× |
| TMDX TransMedics Group, Inc. | 62.5× |
| NEOG Neogen Corporation compare | 63.4× |
| AXGN AxoGen, Inc. compare | 118× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on TMDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement